Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...

Systems aren’t truly random—outcomes are shaped by structure, constraints, and time, just like reliability performance in industrial operations. Early system states are constrained; risk and outcome ...

When formulating diets for sows it is possible to reduce dietary protein by decreasing soybean meal inclusion and increase ...

The platformer had multiplayer, but its Switch 2 upgrade turns it into a full-on party game with tons of minigames to explore.

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

Breaking new science reveals how a specific fiber can decrease liver fat synthesis, increase fat burning, and even turn sugar into proteins. But that's only the ...

New research suggests pain is not a simple signal of injury but a process that unfolds across nerves, spinal cord, and brain.

Therapeutic progress for fibrostenotic Crohn’s disease has been stalled in a paradox: Antifibrotic drugs require endpoints ...

This mind-blowing study revealed how berberine lowers LDL cholesterol through a mechanism that’s completely different from that underlying statins or other drugs.

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

According to results from the IMerge trial, 2 39.8% of patients treated with imetelstat achieved 8 weeks of transfusion independence compared with 15.0% of patients treated with placebo. Respondents ...